Posttransplant Allosensitization in Low Immunological Risk Kidney and Kidney-Pancreas Graft Recipients
Figure 1
Graft survival censored for death with a functioning graft according to anti-HLA antibodies presence at 6 months after transplant. Antibody-positive patients () showed a significantly lower survival rate at 5 years than antibody-negative patients () (91.5% versus 96.4%, resp., log-rank test ).
